Compare INSP & GOF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | INSP | GOF |
|---|---|---|
| Founded | 2007 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 2.3B |
| IPO Year | 2018 | 2006 |
| Metric | INSP | GOF |
|---|---|---|
| Price | $70.41 | $8.60 |
| Analyst Decision | Hold | |
| Analyst Count | 17 | 0 |
| Target Price | ★ $62.80 | N/A |
| AVG Volume (30 Days) | 696.7K | ★ 2.6M |
| Earning Date | 11-02-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 179.43 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $82,050,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $3.95 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 62.18 | N/A |
| 52 Week Low | $38.91 | $8.40 |
| 52 Week High | $147.03 | $15.09 |
| Indicator | INSP | GOF |
|---|---|---|
| Relative Strength Index (RSI) | 56.37 | 27.33 |
| Support Level | $55.37 | N/A |
| Resistance Level | $78.80 | $10.74 |
| Average True Range (ATR) | 3.41 | 0.14 |
| MACD | -0.66 | 0.03 |
| Stochastic Oscillator | 28.77 | 17.25 |
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and All other countries wherein, it generates a majority of its revenue from the United States. Its segment revenues are derived from the sales of its product, the Inspire system, to hospitals and ambulatory surgery centers in the U.S. and in selected countries in Europe and the Asia Pacific region.
Guggenheim Strategic Opportunities Fund is a diversified, closed-end management investment company. The Fund's investment objective is to maximize total return through a combination of current income and capital appreciation. It has single operating segment. Its products are Mutual Funds, Wealth Management SMAS, Institutional SMAS, ETFS, UITS, UCITS, CIT, Closed-End Funds, Private Funds, Rydex Funds, and Variable Insurance funds.